Astellas Pharma Inc (OTCPK:ALPMF)
$ 11.095 -0.0325 (-0.29%) Market Cap: 19.93 Bil Enterprise Value: 24.15 Bil PE Ratio: 54.12 PB Ratio: 2.00 GF Score: 82/100

Q1 2025 Astellas Pharma Inc Earnings Presentation Transcript

Aug 01, 2024 / NTS GMT
Release Date Price: $10.55

Aug 01, 2024 / NTS GMT
Presentation
Aug 01, 2024 / NTS GMT

=====================
Corporate Participants
=====================
* Hiromitsu Ikeda
Astellas Pharma Inc - Chief Communications & IR Officer
* Atsushi Kitamura
Astellas Pharma Inc - Chief Financial Officer, Senior Managing Executive Officer
* Claus Zieler
Astellas Pharma Inc - Chief Commercial Officer

=====================
Conference Call Participants
=====================
* Hidemaru Yamaguchi
Citigroup Global Market - Analyst
* Seiji Wakao
JPMorgan Securities - Analyst
* Akinori Ueda
Goldman Sachs Securities - Analyst
* Kasumi Haruta
UBS Securities - Analyst
* Shinichiro Muraoka
Morgan Stanley MUFG Securities - Analyst
* Kazuaki Hashiguchi
Daiwa Securities - Analyst
* Shinichiro Hyogo
Mitsubishi UFJ Trust and Banking Corporation - Analyst
* Miki Sogi
Sanford C. Bernstein - Analyst
* Tony Ren
Macquarie Capital Securities - Analyst

=================

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot